论文部分内容阅读
目的：探讨爱维治对糖尿病多发性末梢神经病变的治疗效果。方法：把８９例病人随机分为两组，对照组４６例应用川芎嗪治疗，治疗组４３例在应用川芎嗪的基础上加用爱维治治疗，疗程为１５天。结果：对照组总有效率为８０％，显效率１７％；治疗组总有效率为９５％，显效率４４％，两组间有显著差异（Ｐ＜０．０５）。结论：爱维治是治疗该病的有效药物。
Objective: To investigate the treatment of Aventis on diabetic peripheral neuropathy. Methods: 89 patients were randomly divided into two groups, the control group, 46 cases were treated with ligustrazine, the treatment group, 43 cases were treated with ligustrazine on the basis of ligustrazine, the course of treatment was 15 days. Results: In the control group, the total effective rate was 80% and the effective rate was 17%. The total effective rate was 95% and the effective rate was 44% in the control group, with significant difference between the two groups (P <0.05). Conclusion: Aventis is an effective drug to treat the disease.